High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas

Background: Meningiomas are the most common primary central nervous system tumors. 20–30% of these tumors are considered high-grade and associated with poor prognosis and high recurrence rates. Despite the high occurrence of meningiomas, there are no FDA-approved compounds for the treatment of these...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Med
Autores principales: Tatman, Philip D., Wroblewski, Tadeusz H., Fringuello, Anthony R., Scherer, Samuel R., Foreman, William B., Damek, Denise M., Lillehei, Kevin, Youssef, A. Samy, Jensen, Randy L., Graner, Michael W., Ormond, D. Ryan
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303324/
https://ncbi.nlm.nih.gov/pubmed/34300316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10143150
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares